Abstract
Brentuximab Vedotin in Combination with RCHOP As Front-Line Therapy in Patients with DLBCL: Interim Results from a Phase 2 Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have